Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Ionis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Ionis Pharmaceuticals Inc
Rating: 1.790055625
Author: Trendlyne DVM scores

Expensive Performer

about

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

79.44 1.91 (2.46%)

231.69% Gain from 52W Low

3.3M

XNAS Volume

XNAS 21 Jan, 2026 4:30 PM (EST)

Medium Financial Strength

38.9 / 100

Expensive Valuation

7.7 / 100

Technically Neutral

57.8 / 100

Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM

1Yr Price target upside is 14%

22 analysts

Ionis Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ionis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

231.69% Gain from 52W Low

SWOT Analysis

Ionis Pharma Inc Live Price Chart